What Has Been The Evolution of the Protein Engineering Market in Recent Years?
The protein engineering market has seen considerable growth due to a variety of factors.
• In the past few years, the protein engineering market has expanded swiftly. It is projected to increase from $4.11 billion in 2024 to $4.69 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. The remarkable growth during the historical phase can be credited to factors such as scientific advancements, early triumphs in therapeutics, the boom in biopharmaceuticals, the surge of monoclonal antibodies, and the development of regulatory frameworks.
What Are the Future Growth Projections for the Protein Engineering Template Market?
The Protein Engineering market is expected to maintain its strong growth trajectory in upcoming years.
• In the years to come, a swift expansion is anticipated in the protein engineering market size. The market is projected to reach $8.33 billion by 2029, propelled by a compound annual growth rate (CAGR) of 15.5%.
The surge during the forecast period can be linked to the growing demand for therapeutic proteins, progress in biotechnology, drug development and research, increasing chronic diseases occurrences, and an emphasis on precision medicine. Key trends for the forecast period encompass sophisticated protein design tools, high-throughput screening methods, artificial intelligence and machine learning, innovative protein expression systems, and the use of CRISPR and gene editing technologies.
What Are The Core Factors Supporting Growth In The Protein Engineering Market?
The protein engineering market is experiencing growth due to the rising need for protein-based medications. These types of drugs, referred to as therapeutic proteins, utilize proteins for their therapeutic effectiveness. Therapeutic proteins are medically altered versions of proteins naturally found in humans. Protein engineering involves altering protein sequences by inserting, substitifying, or eliminating nucleotides within the gene that produces them. This process is used to adjust protein-based drugs for particular uses. For example, a Lancet Diabetes and Endocrinology journal study indicates that nearly 80 million individuals with type-2 diabetes will need insulin by 2030, a 20% increase. This growing demand for protein-based medications is contributing to the expansion of the protein engineering market.
What Are The Major Segments Within The Global Protein Engineering Market?
The protein engineering market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents, Services And Software
2) By Protein Type: Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, Other Protein Types
3) By Technology: Irrational Protein Design, Rational Protein Design
4) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
Subsegments:
1) By Instruments: Protein Purification Systems, Spectroscopy And Imaging Systems, Mass Spectrometers
2) By Reagents: Enzymes, Antibodies, Labeling And Detection Reagents
3) By Services And Software: Custom Protein Engineering Services, Analytical Services, Consulting Services, Modeling And Simulation Software, Data Analysis Software, Bioinformatics Tools
Pre-Book The Protein Engineering Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Protein Engineering Market?
Leading businesses in the protein engineering sector are concentrating on offering advanced protein engineering foundries to enhance research and industrial applications. Such foundries are full-stack protein engineering facilities allowing designers to speedily and extensively test new proteins using a range of technologies. To illustrate, in April 2023, Adaptyv Bio, an avant-garde nanotechnology and biotechnology firm based in Switzerland, introduced a protein engineering foundry. This integrated lab enables protein engineers to efficiently redo their designs and generate data on their proteins, significantly reducing reagent use, experiment time, and the generated cost per data point in comparison to existing methods. The foundry is crafted to seamlessly blend with AI throughout every stage of the protein production cycle, from sequence planning to experimental procedure scheduling, protocol execution, and comprehensive data and metadata recording. The end goal is to make protein design research accessible to all and expedite the progression of the protein engineering sector.
Who Are the Key Players In The Protein Engineering Market?
Major companies operating in the protein engineering market include:
• Bruker Corporation
• Codexis Inc.
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• GenScript Biotech Corporation
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• New England Biolabs Inc.
• PerkinElmer Inc.
• Amgen Inc.
• InvivoGen
• Enantis s.r.o.
• Promega Corporation
• Merck KGaA
• Aragen Bioscience Inc.
• Creative BioMart
• Waters Corporation
• Genentech Inc.
• Novartis AG
• Pfizer Inc.
• Roche Holding AG
• Sanofi S.A.
• GlaxoSmithKline PLC
• Johnson & Johnson
• Eli Lilly and Company
• AbbVie Inc.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Biogen Inc.
• Abzena plc.
What Is The Most Dominant Region In The Protein Engineering Market?
North America was the largest region in the protein engineering market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
